NSEDCP
KRTX

NJ State Employees Deferred Compensation Plan’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,500
Closed -$1.74M – 486
2023
Q4 		$1.74M Hold
5,500
– – 0.24% 97
2023
Q3 		$930K Hold
5,500
– – 0.14% 161
2023
Q2 		$1.19M Hold
5,500
– – 0.17% 137
2023
Q1 		$999K Buy
5,500
+2,400
+77% +$459K 0.15% 157
2022
Q4 		$609K Hold
3,100
– – 0.1% 221
2022
Q3 		$697K Buy
+3,100
New +$627K 0.12% 188

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

NJ State Employees Deferred Compensation Plan's KRTX Position: Q1 2024 in Review

NJ State Employees Deferred Compensation Plan sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 5,500 shares — an estimated $1.74M sold.

NJ State Employees Deferred Compensation Plan first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $1.74M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • NJ State Employees Deferred Compensation Plan reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 5,500 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.74M.
  • NJ State Employees Deferred Compensation Plan first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • NJ State Employees Deferred Compensation Plan's Karuna Therapeutics, Inc. Common Stock position peaked at $1.74M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q1 2024, filed 2 May 2024.